SIS Ventures

Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.

It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.

Nebu-Flow is focused on developing advanced nebulizers aimed at improving the delivery of treatments for patients with respiratory disorders. The company has created a novel pulmonary drug-delivery technology that facilitates the efficient administration of difficult-to-nebulize medications directly to the lungs. This includes both existing formulations and innovative therapeutics such as biologics, nanomedicines, and vaccines. By enhancing the delivery of these treatments, Nebu-Flow aims to support medical professionals in addressing and curing various respiratory diseases.

Carcinotech is focused on treating cancers and is based at the Roslin Innovation Centre on the outskirts of Edinburgh.

Good-Loop operates an advertising platform that transforms advertising revenue into charitable donations, thereby enhancing the effectiveness and ethics of online advertising. The platform allows users to opt-in to watch video ads without interruption, with 50% of the revenue generated from these ads directed towards a social cause of the viewer's choice. This model not only supports charitable initiatives but also yields higher engagement rates for advertisers; Good-Loop reports an average completion rate of 61% for its ads, significantly surpassing the typical 30% rate seen on platforms like YouTube. By focusing on personalized advertising experiences, Good-Loop aims to create a mutually beneficial scenario for both consumers and advertisers while promoting social responsibility.

Talking Medicines Limited is a data technology company based in Glasgow and London that specializes in capturing, curating, and structuring patient insights related to launched medicines. Utilizing advanced artificial intelligence, machine learning, and natural language processing, the company analyzes real-world conversations and behaviors of patients to map their experiences with medications. Its flagship application, Medsmart, collects data on medication usage, providing pharmaceutical companies with real-time intelligence about patient sentiment and behavior. The company offers various solutions, including a real-world persona data service, digital focus groups, and custom data solutions tailored to specific needs within the pharmaceutical sector. Founded in 2013 and rebranded in 2015, Talking Medicines aims to enhance regulatory compliance and enable marketing strategies through insights that measure patient confidence and identify growth opportunities for pharmaceutical brands.

Trojan Energy Limited specializes in providing charging infrastructure solutions for electric vehicles globally. Founded in 2016 and based in Stonehaven, United Kingdom, the company focuses on the installation of on-street flat and flush electric vehicle charging points. This innovative approach addresses the needs of vehicle owners who lack access to off-street parking, facilitating the broader adoption of electric vehicles.

EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, that specializes in the research, development, and commercialization of orally available products for fecal microbiota transplantation. Founded in 2017, the company focuses on creating microbiome-modulating drugs derived from bacterial communities in the human gastrointestinal tract. These products aim to restore health and prevent bacterial infections by addressing imbalances in gut bacteria associated with various diseases. EnteroBiotix is dedicated to developing both allogenic and autologous microbial therapeutics to meet the needs of patients with serious unmet medical conditions, thereby enabling healthcare providers to effectively prevent and treat debilitating infections and diseases.

Trojan Energy Limited specializes in providing charging infrastructure solutions for electric vehicles globally. Founded in 2016 and based in Stonehaven, United Kingdom, the company focuses on the installation of on-street flat and flush electric vehicle charging points. This innovative approach addresses the needs of vehicle owners who lack access to off-street parking, facilitating the broader adoption of electric vehicles.

Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.

Cyan Forensics Ltd. develops and markets innovative digital forensics tools designed specifically for law enforcement agencies. Founded in 2016 and based in Edinburgh, United Kingdom, the company specializes in extracting digital fingerprints from existing databases of contraband. Its technology enables the scanning of seized computers, hard drives, and other media devices to identify harmful content, specifically targeting materials related to paedophiles and terrorists. By providing detailed results, Cyan Forensics helps forensic analysts focus their investigative efforts on devices likely to yield incriminating evidence, thus streamlining the investigative process and ensuring that time is not wasted on irrelevant materials. The tools developed by the company are also valuable in delivering evidence that can be used in court proceedings.

Manus Neurodynamica Ltd manufactures medical diagnostic technologies for neuromotor impairments, including the non-invasive diagnosis and monitoring of Parkinson’s disease. Its technologies are used in academic research, pharmaceutical research, and non-medical applications. The company was founded in 2008 and is based in North Shields, United Kingdom.

It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.

Trojan Energy Limited specializes in providing charging infrastructure solutions for electric vehicles globally. Founded in 2016 and based in Stonehaven, United Kingdom, the company focuses on the installation of on-street flat and flush electric vehicle charging points. This innovative approach addresses the needs of vehicle owners who lack access to off-street parking, facilitating the broader adoption of electric vehicles.

Cyan Forensics Ltd. develops and markets innovative digital forensics tools designed specifically for law enforcement agencies. Founded in 2016 and based in Edinburgh, United Kingdom, the company specializes in extracting digital fingerprints from existing databases of contraband. Its technology enables the scanning of seized computers, hard drives, and other media devices to identify harmful content, specifically targeting materials related to paedophiles and terrorists. By providing detailed results, Cyan Forensics helps forensic analysts focus their investigative efforts on devices likely to yield incriminating evidence, thus streamlining the investigative process and ensuring that time is not wasted on irrelevant materials. The tools developed by the company are also valuable in delivering evidence that can be used in court proceedings.

Talking Medicines Limited is a data technology company based in Glasgow and London that specializes in capturing, curating, and structuring patient insights related to launched medicines. Utilizing advanced artificial intelligence, machine learning, and natural language processing, the company analyzes real-world conversations and behaviors of patients to map their experiences with medications. Its flagship application, Medsmart, collects data on medication usage, providing pharmaceutical companies with real-time intelligence about patient sentiment and behavior. The company offers various solutions, including a real-world persona data service, digital focus groups, and custom data solutions tailored to specific needs within the pharmaceutical sector. Founded in 2013 and rebranded in 2015, Talking Medicines aims to enhance regulatory compliance and enable marketing strategies through insights that measure patient confidence and identify growth opportunities for pharmaceutical brands.